Copley Acquisition and Ignite Proteomics Terminate Business Combination Agreement
The parties agreed to terminate the agreement effective Oct. 9, 2026, with no termination fees. Each party will bear its own expenses.
Copley Acquisition and Ignite Proteomics agreed to terminate their Business Combination Agreement effective Oct 9, 2026. The termination is mutual, carries no termination fees, and includes mutual releases, with each party bearing its own expenses. Related ancillary agreements, including support, i…